2026年7月19日 19:48 ET 发布 · 更新于 4 个月前 · 3 个来源
Samsung Biologics Agrees to Buy PolyPeptide in $1.8 Billion Deal
bloomberg
·
原始报道
Samsung Biologics Co. has agreed to acquire Switzerland’s PolyPeptide Group AG in an all-cash deal that values the contract drugmaker’s equity at about 1.46 billion Swiss francs ($1.8 billion), expanding its manufacturing capabilities.
原文